Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 877 across all filing types
Latest filing 2016-01-15 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical erhåller CE-märkning för sin femte produkt, EpioscopyTM Damage Assessment Tool
Regulatory Filings Classification · 95% confidence The document is titled "Pressmeddelande" (Press Release) and announces a specific business event: receiving CE marking for a new product, EpioscopyTM Damage Assessment Tool. It details the product, its market potential, and includes quotes from the CEO. This format strongly suggests a general corporate announcement rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a press release announcing a significant operational/product development milestone, and it doesn't fit the specific categories like DIRS, DIV, or CAP, the most appropriate general category for non-standard regulatory announcements is 'Regulatory Filings' (RNS), which often serves as a catch-all for press releases that aren't explicitly covered elsewhere, especially when the text is short and focused on a single announcement. However, given the context of financial reporting databases, a press release announcing a product milestone that is not strictly financial results or a major corporate action might sometimes be categorized as 'Regulatory Filings' (RNS) or potentially 'Report Publication Announcement' (RPA) if it were announcing the publication of a report. Since this is a direct announcement of an achievement (CE marking), RNS is the best fit among the provided options as a general regulatory/public disclosure announcement.
2016-01-15 Swedish
Episurf Medical receives CE mark for its fifth product, EpioscopyTM Damage Assessment Tool
Regulatory Filings Classification · 95% confidence The document is titled "Company Announcement" and dated January 15, 2016. It details a specific operational achievement: receiving a CE mark for a new product, EpioscopyTM Damage Assessment Tool. This is not a standard periodic financial report (like 10-K or IR), nor is it a management discussion (MDA) or earnings release (ER). It is a specific, material announcement regarding product development and regulatory clearance, which is best categorized as a general regulatory announcement or news release that doesn't fit the highly specific financial/governance codes. Given the options, 'Regulatory Filings' (RNS) serves as the best general category for significant, non-financial operational news releases that are mandated for disclosure, especially since it concludes with a statement about disclosing information in accordance with securities acts.
2016-01-15 English
Episurf Medical AB utser Pareto Securities till likviditetsgarant
Regulatory Filings Classification · 99% confidence The document is a short press release dated January 13, 2016, announcing that Episurf Medical AB has appointed Pareto Securities as a liquidity provider (likviditetsgarant) for its stock on Nasdaq Stockholm, effective January 15, 2016. This action is related to maintaining market stability and liquidity for the stock. This type of announcement, which concerns market operations, share trading, or specific financial arrangements not covered by other specific codes (like DIV, SHA, or POS), fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory announcement, or potentially 'Capital/Financing Update' (CAP) if viewed as a market structure financing tool. Given the focus is on market liquidity provision rather than a direct capital raise or share transaction, RNS is the most appropriate fallback for a specific market announcement that doesn't fit the other detailed categories.
2016-01-13 Swedish
Episurf Medical AB appoints Pareto Securities as market maker
Share Issue/Capital Change Classification · 99% confidence The document is a short 'Company Announcement' dated January 13, 2016, regarding the appointment of Pareto Securities as a market maker to increase share liquidity. This type of announcement, which details a specific corporate action related to trading or market structure but does not fit neatly into standard financial reporting (like 10-K, ER, or IR), is best classified as a general regulatory announcement. Since it is not a dividend notice (DIV), director dealing (DIRS), capital change (SHA/CAP), or a report publication announcement (RPA), the most appropriate fallback category is Regulatory Filings (RNS). The document length is very short (1770 chars), but it is the primary content, not an announcement *about* another report.
2016-01-13 English
Episurf Medical receives CE mark for its fourth product, the EpiGuide® MOS
Regulatory Filings Classification · 95% confidence The document is titled "Company Announcement" and details the receipt of a CE mark for a new product, EpiGuide® MOS, and outlines plans for its market launch. This is a specific operational update concerning product approval and commercial strategy, not a standard financial filing like a 10-K, IR, or ER. It is a general corporate announcement regarding product development and regulatory milestones. Since there is no specific category for 'Product Approval Announcement' or 'Operational Update', and it is not a standard regulatory filing like a major financial report or insider trade, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a formal announcement made to the market, often required by listing rules, that doesn't fit the other specific financial or governance codes.
2015-12-21 English
Episurf Medical erhåller CE-märkning för sin fjärde produkt, EpiGuide® MOS
Regulatory Filings Classification · 95% confidence The document is a press release dated December 21, 2015, announcing that Episurf Medical has received CE marking for its fourth product, EpiGuide® MOS. It details the product's function (a patient-specific guide instrument for mosaicplasty) and mentions future market launch plans. This type of announcement, which is a specific operational/product update rather than a mandatory financial filing (like 10-K, ER, or IR), fits best under the general category for regulatory or significant operational announcements that don't fit elsewhere. Since it is a specific announcement about a product milestone (CE marking) and not a general regulatory filing fallback (RNS), and it is not a standard financial report, it is classified as a Regulatory Filing (RNS) as it is a public announcement of a significant event, often disseminated via regulatory channels, or as a general announcement. Given the options, RNS is the most appropriate catch-all for non-standard, non-financial regulatory news releases. It is not an ER, IR, or 10-K, nor is it a management change (MANG) or dividend notice (DIV).
2015-12-21 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.